Preferred Label : Episodic ataxia, type 1;
Symbol : EA1;
CISMeF acronym : AEM; AEMK; EAM; EA1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Episodic ataxia with myokymia; Ataxia, episodic, with myokymia; Paroxysmal ataxia with neuromyotonia, hereditary; Myokymia with periodic ataxia; EAM; AEM; AEMK;
Included titles and symbols : Myokymia 1; Continuous muscle fiber activity, hereditary; Isaacs-mertens syndrome; Myokymia 1 with or without hypomagnesemia;
Description : Episodic ataxia is a neurologic condition characterized by spells of incoordination
and imbalance, often associated with progressive ataxia (Jen et al., 2007). - Genetic
Heterogeneity of Episodic Ataxia Episodic ataxia is a genetically heterogeneous disorder.
See also EA2 (108500), caused by mutation in the CACNA1A gene (601011) on chromosome
19p13; EA3 (606554), which has been mapped to chromosome 1q42; EA4 (606552); EA5,
caused by mutation in the CACNB4 gene (601949) on chromosome 2q22-q23; EA6 (612656),
caused by mutation in the SLC1A3 gene (600111) on chromosome 5p13, and EA7 (611907),
which has been mapped to chromosome 19q13. Isolated myokymia-2 (see 121200) is associated
with mutation in the;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the potassium voltage-gated channel, shaker-related subfamily,
member 1 gene (KCNA1, 176260.0001);
Laboratory abnormalities : Increased serum creatine kinase during episodes;
Prefixed ID : #160120;
Origin ID : 160120;
UMLS CUI : C1719788;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)